The corporate net worth or market capitalization of Charles River Laboratories hovers around 13.5 billion US dollars, reflecting its total equity value on public stock exchanges. Furthermore, the enterprise generates robust annual consolidated revenues surpassing four billion US dollars, backed by a massive asset base of advanced laboratory facilities, specialized research models, and high-performance manufacturing infrastructure distributed globally.